Skip to main content
. 2018 Jul 8;176(10):1370–1383. doi: 10.1111/bph.14382

Figure 5.

Figure 5

Diagram summarizing four important advantages of possible cannabinoid‐based therapies for the treatment of neurodegenerative disorders when compared with the other therapeutic strategies investigated to date. CB2 receptor‐immunolabelled cells (in red and marked with arrows in the left bottom corner) are much more frequent in ALS tissue than in control tissue, corresponding to reactive microglia (in green and marked with arrows).